UCI Health expands ENT and ophthalmology access - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

UCI Health expands ENT and ophthalmology access

Newly opened UCI Health — Brea Outpatient Center increases access to academic-focused care

  • February 13, 2026

  • 1 min

Share

Clinical Report: UCI Health expands ENT and ophthalmology access

Overview

{'add': 'Located at 380 W. Central Ave.'}

Background

{'add': 'Examples of conditions managed include chronic sinusitis and diabetic retinopathy.'}

Data Highlights

No numerical data provided in the source material.

Key Findings

{'add': 'Services include general ENT, laryngology, rhinology, otology, and head and neck surgery consults.'}

Clinical Implications

{'add': 'Improved access may lead to better patient outcomes.'}

Conclusion

{'add': "Highlight the center's role in addressing community health needs."}

Related Resources & Content

  1. UCI Health, UCI Health makes history in 2025, 2025 -- UCI Health makes history in 2025
  2. UCI Health, Physician Network welcomes two new additions, 2026 -- Physician Network welcomes two new additions
  3. UCI Health, UCI Health named top 5 in nation for outpatient care by Vizient, 2025 -- UCI Health named top 5 in nation for outpatient care by Vizient
  4. American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), CPG: Surgical Management of Chronic Rhinosinusitis, 2025 -- CPG: Surgical Management of Chronic Rhinosinusitis
  5. PubMed, Diabetic Retinopathy Preferred Practice Pattern®, 2025 -- Diabetic Retinopathy Preferred Practice Pattern®
  6. uci health — UCI Health expands physician network with leading physical therapy partners
  7. CPG: Surgical Management of Chronic Rhinosinusitis - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
  8. Diabetic Retinopathy Preferred Practice Pattern® - PubMed

Original Source(s)

UCI Health expands ENT and ophthalmology access

  • February 13, 2026

Related Content

Evaluation of Standard versus Enhanced Bilateral Lateral Rectus Recession Techniques for Intermittent Exotropia

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.